S Skurtveit1,2, J G Bramness3, V Hjellvik1, I Hartz1,4, R Nesvåg5, L J Hauge1, M Handal1. 1. Norwegian Institute of Public Health, Oslo. 2. Norwegian Centre for Addiction Research, University of Oslo, Oslo. 3. Norwegian National Advisory Unit on Concurrent Substance Abuse and Mental Health Disorders, Innlandet Hospital Trust, Hamar. 4. Section for Research and Development, Innlandet Hospital Trust, Brumunddal. 5. The Norwegian Medical Association, Oslo, Norway.
Abstract
OBJECTIVE: To study if the observed increase in use of antidepressants (AD) among adolescents may be explained by higher incidence of depressive disorder diagnosis, increasing treatment of other mental disorders or more liberal prescribing practice. METHODS: We used three different study populations of girls and boys aged 13-17 years in Norway: 1) individuals who were diagnosed with depressive disorders in primary health care, 2) individuals who were diagnosed with depressive disorders in secondary health care; 3) individuals who were dispensed ADs as recorded in the prescription database. Dataset 2) and 3) were linked. RESULTS: Incidence of depressive disorders increased from 2010 to 2015 both in primary and secondary health care, especially in girls. One in four girls with incident depressive disorders was prescribed ADs and this proportion was stable over time. Among girls treated with ADs the proportion with a diagnosis where AD treatment is indicated increased from 61.1% to 66.0%. Furthermore, the proportion with moderate or severe episodes of major depressive disorders was stable and high, 72.9% in 2014. CONCLUSION: The only issue studied that could explain increasing AD use in girls was increasing incidence of depressive disorders. Most adolescents with incident diagnosis of depressive disorders were not treated with ADs.
OBJECTIVE: To study if the observed increase in use of antidepressants (AD) among adolescents may be explained by higher incidence of depressive disorder diagnosis, increasing treatment of other mental disorders or more liberal prescribing practice. METHODS: We used three different study populations of girls and boys aged 13-17 years in Norway: 1) individuals who were diagnosed with depressive disorders in primary health care, 2) individuals who were diagnosed with depressive disorders in secondary health care; 3) individuals who were dispensed ADs as recorded in the prescription database. Dataset 2) and 3) were linked. RESULTS: Incidence of depressive disorders increased from 2010 to 2015 both in primary and secondary health care, especially in girls. One in four girls with incident depressive disorders was prescribed ADs and this proportion was stable over time. Among girls treated with ADs the proportion with a diagnosis where AD treatment is indicated increased from 61.1% to 66.0%. Furthermore, the proportion with moderate or severe episodes of major depressive disorders was stable and high, 72.9% in 2014. CONCLUSION: The only issue studied that could explain increasing AD use in girls was increasing incidence of depressive disorders. Most adolescents with incident diagnosis of depressive disorders were not treated with ADs.
Authors: Christoph Berger; Alexander Dück; Stephanie Gest; Lena Jonas; Michael Kölch; Franziska Martin; Olaf Reis; Jennifer Schroth; Tanja Legenbauer; Martin Holtmann Journal: Front Psychiatry Date: 2022-05-12 Impact factor: 5.435
Authors: Lukasz Cybulski; Darren M Ashcroft; Matthew J Carr; Shruti Garg; Carolyn A Chew-Graham; Nav Kapur; Roger T Webb Journal: BMC Psychiatry Date: 2021-05-03 Impact factor: 3.630